US 8044033
Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer
granted A61KA61K31/415A61K31/7072
Quick answer
US patent 8044033 (Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/415, A61K31/7072, A61P, A61P35/00